Perfil do atendimento oncológico e utilização dequimioterápicos em pacientes do Hospital Mário Penna

Abstract

Hospital Mário Penna (HMP) is a philanthropic institution specialized inoncology care, which is financially supported by Associação dos Amigos do Hospital Mário Penna, a non-profitable association. It is located in Belo Horizonte, the capital of Minas Gerais and its capacity is limited to 60 hospital beds. The hospital is a reference health care facility for oncology patients only, considered by Brazilian Government, as a High Complexity Oncology Center, Level II (CACON II). Most patients belong to a low socio-economic level and depend on the Brazilian public health care system. This study shows the results of a five-year study of cancer data collection and consolidation (2000 to 2004) at Hospital Cancer Registries (RHC). It also compares analytical and non-analytical cases attended at this time-period and analyses the consumption of chemotherapeutic drugs against the most incident tumors recorded in the second semester of the year 2006, comparing treatments with medical protocols recommended by current scientific worldwide reference literature. The RHC plays a relevant role as a source of data on cancer diagnosis,treatment and patients evolution. Those data are collected from hospital patient reports and input onto SISRHC software, a specific hospital based electronic processing data device developed by Instituto Nacional do Câncer (INCA) a Brazilian government health agency. The general results show that 7,446 patients were considered as analyticalcases, which means that they had their cancer diagnosis made and treatment carried out at HMP, 51.6% of them are male. The most frequent tumors recorded on this population are uterine cervix, prostate, esophagus and breast cancer (50.0%). The data also show that 93.4% of them arrived at hospital with no previous cancer treatment and the absence of staging cancer data was recorded in 58.0% of the cases.The non-analytical cases reached 4,081 patients. 54.5% of them are female. The most frequent tumors recorded on this non-analytical population were uterine cervix, prostate, esophagus and breast cancer (56.0%), the same types of cancer found in the analytical cases population. The number of patients which arrived in thehospital with no previous treatment ranged from 66.0% to 79.0% with no staging cancer information adding up to 67.0% (superior to the rate recorded on analytical case). The analysis of consumption of chemotherapeutic medicine, from June to December 2006, shows that 491 patients started chemotherapy treatment at HMP,being the majority female (327 patients, 66.6%). The analysis of the use of those drugs on breast, stomach, uterine cervix, prostate and bladder tumors treatment and the comparison with the recommendation found in National Comprehensive Cancer Network (NCCN), National Cancer Institute (NCI) and Associação Médica Brasileira/Conselho Federal de Medicina (AMB/CFM) show that the procedures done at HMP were efficient and in accordance with the international scientific medical literature.